Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Celldex Therapeutics buy Stifel Nicolaus

Celldex Therapeutics
Start price
€33.20
18.06.24 / 50%
Target price
€54.03
18.06.25
Performance (%)
-45.18%
End price
€18.20
19.06.25
Summary
This prediction ended on 19.06.25 with a price of €18.20. The BUY prediction by Stifel_Nicolaus for Celldex Therapeutics performed very badly with a performance of -45.18%. Stifel_Nicolaus has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Stifel_Nicolaus has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Celldex Therapeutics 7.545% 7.545% 86.115%
iShares Core DAX® 2,29 % 9,96 % 14,44 %
iShares Nasdaq 100 4,54 % 8,79 % 40,87 %
iShares Nikkei 225® 2,81 % 14,08 % 47,19 %
iShares S&P 500 3,10 % 6,85 % 31,17 %

Comments by Stifel_Nicolaus for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Buy
Perf. (%) -45.18%
Target price 54.033
Change
Ends at 18.06.25

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat

Stifel Nicolaus 
0
Report Share
18.06.24
In the thread Trading Celldex Therapeutics
Prediction Buy
Perf. (%) -45.18%
Target price 54.033
Change
Ends at 18.06.25

Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten

Stifel Nicolaus 
0
Report Share
19.06.25

Current prediction by Stifel_Nicolaus for Celldex Therapeutics

buy
Celldex Therapeutics

Start price
Target price
Perf. (%)
€26.00
26.02.26
€57.53
26.02.27
12.15%
20.04.26

Stifel Nicolaus 
26.02.26 50%